Business · 1 sources covering this

Symbiotec Pharmalab IPO Day 3: Issue Fully Subscribed; NIIs Lead With 5.58x Bids

The IPO is being offered in the price band of Rs 938-988 per share, valuing the pharmaceutical ingredients maker at around Rs 6,350 crore at the upper end of the band.

Share:WhatsApp X Reddit Facebook LinkedIn

Coverage spectrum

0 L · 1 C · 0 R

How 1 sources are covering this

NDTVCenter·2h ago
Symbiotec Pharmalab IPO Day 3: Issue Fully Subscribed; NIIs Lead With 5.58x Bids
The IPO is being offered in the price band of Rs 938-988 per share, valuing the pharmaceutical ingredients maker at around Rs 6,350 crore at the upper end of the band.
Read at NDTV →

Embed this bias spectrum on your site

Paste this iframe wherever you'd like the widget to appear. Resizes responsively; no JS required.

<iframe
  src="https://hindustansphere.com/embed/cluster/6a8a4cec7fc87bc572afbd1389f77bcf6aaa43e7"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="Symbiotec Pharmalab IPO Day 3: Issue Fully Subscribed; NIIs Lead With 5.58x Bids"></iframe>

Symbiotec Pharmalab IPO Day 3: Issue Fully Subscribed; NIIs Lead With 5.58x Bids

How 1 sources are covering this

Symbiotec Pharmalab IPO Day 3: Issue Fully Subscribed; NIIs Lead With 5.58x Bids

More from Business

PM Modi flags ‘unacceptable’ quality issues in infra projects, questions need for ‘fourth-party audit’: Report

What makes a great investor?

At least three Indian oil companies plan to avoid ships on Iran’s new blacklist: report

Bill Gates seeks meeting with Xi Jinping to push global AI safety efforts

Reader

Trust & legal

Across the network